Neurology Flashcards

1
Q

Focal seizure

A

affects one side of the brain

Aware or impaired awareness
Motor or nonmotor
Focal or bilateral tonic-clonic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Generalized onset

A

Affects both sides of the brain

Absence (nonmotor)
Myoclonic (motor) - brief jerking movements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Tonic-clonic

A

5 phases:
Flexion
Extension
Tremor
Clonic
Postictal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Status epilepticus

A

Prolonged seizure of >5 minutes

After 30 minutes, long-term consequences possible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Automatisms

A

Associated with focal seizures - may occur before seizure

Lip smacking, chewing, swallong, tongue movements, scratching, thrashing arms/legs, fumbling with clothing, snapping fingers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Carbamazepine alleles

A

HLA-B*1502 - increased risk of SJS (Asian population)

HLA-B*3101 - increased risk of hypersensitivity (not tested routinely)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Phenytoin equivalents (PE)

A

1.5mg fosphenytoin = 1mg phenytoin (1 PE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Dosing, administration rate fosphenytoin

A

Load: 10-20mg PE/kg IV or IM
Maintenance: 4-6 PE/kg/day in divided doses after load

Max infusion rate 150mg PE per minute (risk of severe hypotension, cardiac arrhythmias)

Less risk of phlebitis than phenytoin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lamotrigine & Valproic Acid

A

Valproic acid decreases lamotrigine concentration

Lower starting and maintenance doses of lamotrigine needed to prevent ADRs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Estrogen effects on antiepileptics

A

Lamotrigine: estrogen OCPs increase clearance of lamotrigine so higher doses needed

Valproic acid: estrogen OCPs decrease VPA serum concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Antiepiletic drugs that are enzyme inducers

A

Carbamazepine
Cenobamate (CYP3A4)
Fosphenytoin
Oxcarbazepine
Phenobarbital
Phenytoin
Primidone
Vigabatrin (CYP2C9)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Phenytoin drug interactions

A

Increase phenytoin:
Anticoagulatns
Chloramphenicol
Cimetidine
Diltiazem
Disulfiram
Isoniazid
Phenybutazone
Sulfa-TMP

Decreased phenytoin:
Antineoplastics
Diazoxide
Folic acid
Rifampin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Carbamazepine drug interactions

A

Decrease carbamazepine:
Theophylline

Increase carbamazepine:
Cimetidine
Diltiazem, verapamil
Erythromycin
Isoniazid
Nefazodone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Valproic Acid drug interactions

A

Increase VPA:
Salicylates

Decreased VPA:
Estrogen OCPs
Meropenem
Rifampin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Carbamazepine therapeutic level

A

4-12 mcg/ml

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Phenobarbital therapeutic level

A

15-40 mcg/ml

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Phenytoin therapeutic level

A

10-20 mcg/ml

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Valproic acid therapeutic level

A

40-100 (150) mcg/ml

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Zonisamide cross reactivity

A

Avoid in patients with sulfa allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Lamotrigine starting dose

A

Typical: 25mg daily

with VPA: 25mg every other day

with inducers (carbamazepine, phenytoin, phenobarbital, primidone): 50mg daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Status epilepticus Principles

A
  1. Ascertain ABCs
  2. Obtain lab (BG, BMB, BMP, Ca, Mg, serum conc)
  3. BG < 60: admin thiamine 100mg IV followed by D50%
  4. Administer emergency medication to stop seizure
  5. Administer urgent medication to prevent seizure

Administer drugs parenterally. Do not administer NMBAs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Emergency Meds for Status Epilepticus

A

Lorazepam (DOC) 0.1mg/kg (max 4mg) at rate of 2mg/min

Diazepam 0.15mg/kg (max 10mg) at rate of 5mg/min

Midazolam (IM) 0.2mg/kg (max 10mg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Urgent Meds for Status Epilepticus

A

FDA approved:
Phenytoin 20mg/kg
Fosphenytoin
Phenobarbital 20mg/kg

Non-FDA approved:
Valproic Acid 20-40mg/kg
Levetiracetam 40-60mg/kg
Lacosamide 200-400mg bolus

24
Q

Refractory status epilepticus meds

A

If BZD resistant: fosphenytoin, levetiracetam, or valproate

Pentobarbital (ventilator)
Midazolam drip
Propofol (ventilator)

25
Q

Epilepsy in Pregnancy

A

Avoid valproate acid as much as possible in nonpregnant and pregnant women

Avoid phenytoin, carbamazepine, and phenobarbital

Consider monitoring serum concentrations during pregnancy

26
Q

Antiepileptics that decrease effect of OCP, patch, ring, progesterone implant

A

Carbamazepine
Lamotrigine
Oxcarbazepine
Phenobarbital
Phenytoin
Primirdone
Topiramate (>200mg)

Others: brivaracetam, cenobamate, clobazam, eslicarbazepine, felbamate, perampanel, rufinamide

Recommend Medroxyprogesterone injection or levonorgesterol IUD

27
Q

Suicide risk in antiepileptics

A

All anti-epileptic meds have this warning (most siG: levetiracetam, phenobarb, primidone, topiramate, vigabatrin, tiagabine, perampanel)

Increased risk between week 1 thru week 24 of therapy

28
Q

Wearing-off phenomenon

A

Assoc w/ Carbidopa/Levodopa

Return of Parkinson’s symptoms before next dose

Add on therapies: DA agonist, MAO-B inhibitor, COMT inhibitor (entacapone, opicapone), increasing frequency/dose of levodopa

29
Q

On-off phenomenon

A

Assoc with Carbidopa/Levodopa

Unpredictable return of Parkinson disease symptoms without respect to dosing interval

Add on therapies: entacapone, MAO-B inhibitors (rasagiline, selegiline), DA agonist (pramipexole, ropinirole, apomorphine)

30
Q

Dyskinesia in PD

A

Assoc w/ Carbidopa/Levodopa

Drug-induced involuntary movements

Treatment: decrease levodopa dose, add amantadine

31
Q

MAO-B inhibitors

A

Increase dopamine in brain

Selegiline
Rasagiline
Safinamide

Caution serotonin syndrome (meperidine, other serotonergic meds)

Available as tabs and ODTs. Metabolized to amphetamine. Rasagiline interacts with Ciprofloxacin.

32
Q

Carbidopa/levodopa

A

Carbidopa prevents peripheral conversion of levodopa to dopamine, thus increasing amount of levodopa to cross BBB and increase dopamine

Long-term ADRs = wearing-off phenomenon, on-off phenomenon, dyskinesias

Slow release as delay to effect so may need to combine with IR form

Greatest benefit for rigidity and bradykinesia > tremor, postural instability

32
Q

Dopamine agonists

A

Apomorphine
Bromocriptine
Pramipexole
Ropinirole
Rotigotine

Titrate to effect
Dopamine related ADRs - impulsive behavior, N/V, postural hypotension

33
Q

Apomorphine

A

DA agonist that treats off-episodes by SC inj

CI: 5HT3 antagonists (ondansetron, etc), sulfite allergy

Trimethobenzamide helps nausea

Complex dose initiation, must be done in setting w/ BP monitoring

34
Q

Anticholinergics for PD

A

Trihexyphenidyl, benztropine

Useful only for tremor

35
Q

Amantadine for PD

A

Reduces dyskinesias

36
Q

COMT inhibitors

A

Prevent breakdown of dopamine to increase amount of levodopa crossing BBB
Must be used with carbidopa/levodopa

Tolcapone (severe restriction)
Entacapone
Opicapone

Diarrhea may occur after 2 weeks of initiation
Orange urine

37
Q

Pimavanserin

A

approved for PD psychotic disorder

38
Q

Antipsychotic preference in PD

A

Quetiapine or clozapine

Avoid typical antipsychotics, risperidone, olanzapine as they worsen motor features

39
Q

Migraine highlights

A

Unilateral, pulsating, mod-severe intensity, aggravation by walking

Nausea, vomiting, photophobia, phonophobia

+/- aura

40
Q

Tension headache highlights

A

Pressing or tightening (nonpulsating), mild-moderate, bilateral, no aggravation with walking

41
Q

Cluster headache highlights

A

Several episodes of unilateral, orbital, supraorbital or temporal pain

Conjuctival injection, lacrimation, nasal congestion, rhinorrhea, facial sweating, miosis, ptosis, eyelid edema

42
Q

Calcitonin gene-related peptide antagonists

A

Refractory prophylaxis:

SC:
Erenumab-aooe (aimovig)
Fremanezumab-vfrm (ajovy)
Galcanezumab-gnlm (emgality)

IV:
Eptinezumab (vyepti)

PO:
Atogepant (qulipta)
Rimegepant (Nurtec ODT)

Acute:

Ubrogepant
Rimegepant
Zavegepant (intranasal)

43
Q

Alternate routes for triptans

A

SC:
sumatriptan

Intranasal:
sumatriptan
zolmitriptan

ODT:
zolmitriptan
rizatriptan

44
Q

Triptan & Ergot CI

A

CAD
stroke
uncontrolled HTN
peripheral vascular disease
ischemic bowel disease
pregnancy

45
Q

Triptan DI

A

MAO-I (do not use within two weeks)

Propranolol & rizatriptan (propranolol 5mg max per dose)

46
Q

Antiemetics for migraine

A

Prochlorperazine
Metoclopramide
Chlorpromazine

47
Q

Tension HA Prophylaxis

48
Q

Tension HA Acute Tx

A

APAP
NSAIDs (aspirin, ibuprofen, naproxen, ketoprofen, ketorolac)
w or w/o caffeine

49
Q

Cluster HA Prophylaxis

A

Verapamil
Melatonin
Suboccipital inj of betamethasone
Lithium <0.3
Warfarin
Galcanezumab-gnlm
Steroids (prednisone 40-60mg/day taper over 3 weeks)

50
Q

Cluster HA Acute

A

Oxygen 6-12 L/min

SC triptan > intranasal in efficacy

51
Q

MS drug for pregnancy

A

Dimethyl fumarate (Tecfidera)

Natalizumab (Tysarbi) - possibly

Avoid all others in pregnancy

52
Q

MS therapies for spasticity

A
  1. baclofen, tizanidine
  2. dantrolene, diazepam
  3. intrathecal baclofen, gabapentin
  4. botox
53
Q

Dalfampirdine (Ampyra)

A

Treatment for walking impairment in MS – improves walking speed
10mg BID

54
Q

Dextromethorphan/quinidine

A

Treatment for pseudobulbar affect (espidoes of inappropriate laughing/crying)

Quinidine blocks first pass metabolism of DM, increasing DM concentrations